Avidity Biosciences (RNA) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

• Last SEC data release: 2025-12-31
• Last 15 days FTD volume: £4.23 M
• Last 3 months FTD volume: £22.62 M
• Last 12 months FTD volume: £49.37 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNA) - since 2020

Avidity Biosciences (RNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
PTC Therapeutics PTCT	£12.7 M	£41.61 M	🇺🇸 USA
Acorda Therapeutics ACOR	N/A	£0.01 M	🇺🇸 USA
Sarepta Therapeutics SRPT	£3.41 M	£20.54 M	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	£0.17 M	£0.91 M	🇺🇸 USA
Fate Therapeutics FATE	£0.59 M	£1.38 M	🇺🇸 USA
Pfizer PFE	£55.69 M	£0.12 B	🇺🇸 USA
GSK plc GSK	£49.05 M	£0.36 B	🇬🇧 UK